Genomic information can be used to predict an individual's risk of developing cancer. For instance, mutations in the BRCA1 and BRCA2 genes are associated with a higher risk of breast and ovarian cancers. Genetic testing for these mutations can help identify individuals at higher risk, enabling proactive monitoring and preventive measures.
